<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2021-34-39-44</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-2345</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДЕРМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DERMATOLOGY</subject></subj-group></article-categories><title-group><article-title>Баланопоститы: вопросы классификации, диагностики и подходы к терапии</article-title><trans-title-group xml:lang="en"><trans-title>Balanoposthitis: issues of classification, diagnosis and approaches to therapy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3048-2488</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Игнатовский</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ignatovsky</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Игнатовский Андрей Викторович, к. м. н., доцент кафедры инфекционных болезней, эпидемиологии и дерматовенерологии</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Ignatovskii Andrei V., Ph D., associate professor at Dept of Infectious Diseases, Epidemiology and Dermatovenereology</p><p>Saint Petersburg</p></bio><email xlink:type="simple">derm@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Санкт-Петербургский государственный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint Petersburg State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>17</day><month>12</month><year>2021</year></pub-date><volume>0</volume><issue>34</issue><issue-title>Дерматология (3)</issue-title><fpage>39</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Игнатовский А.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Игнатовский А.В.</copyright-holder><copyright-holder xml:lang="en">Ignatovsky A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/2345">https://www.med-alphabet.com/jour/article/view/2345</self-uri><abstract><sec><title>Цель работы</title><p>Цель работы. На основании анализа публикаций представить вариант современной классификации процессов, протекающих с поражением половых органов, обратить внимание специалистов на особенности и многообразие причин, приводящих к воспалению головки и крайней плоти, а также обсудить актуальные вопросы наружной терапии баланопоститов.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. При подготовке публикации использованы данные современных исследований и клинических рекомендаций.</p></sec><sec><title>Результаты</title><p>Результаты. Многообразие вариантов поражения головки и крайней плоти может быть обусловлено целым рядом причин и быть как самостоятельным локальным процессом, так и фрагментом дерматоза, где возможно поражение в виде баланопостита. Также при обследовании и выборе варианта терапии важно учитывать возможную роль микроорганизмов, спектр которых как причины баланопостита разнообразен от аэробной и анаэробной, до вирусной и грибковой микрофлоры. Подходы к лечению определяются этиологическими факторами.</p></sec><sec><title>Выводы</title><p>Выводы. Баланопоститы представляют собой гетерогенную группу нозологий. Выбор лечения осуществляется с учетом выявленной причины или эмпирически, когда это возможно. Наружная терапия и гигиена составляют существенную часть лечения. Выбирая препараты топических глюкокортикостероидов, следует отдавать предпочтение препаратам, обладающим высоким терапевтическим индексом и низким атрофогенным потенциалом. Диспластические процессы полового члена ассоциируются с папилломавирусной инфекцией, лечение которых может быть как консервативным, так и с применением деструктивных методов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To present a variant of the modern classification of the processes occurring with lesions of the genitals, to draw specialists’ attention to the peculiarities and variety of causes leading to inflammation of the glans and foreskin, as well as to discuss topical issues of external therapy of balanopostitis.</p></sec><sec><title>Material and methods</title><p>Material and methods. Data from modern studies and clinical guidelines were used in the preparation of the publication.</p></sec><sec><title>Results</title><p>Results. The variety of variants of lesions of the glans and foreskin can be due to a number of reasons and can be either an independent local process or a fragment of dermatosis, where it is possible to be affected in the form of balanoposthitis. Also, when examining and selecting therapy options, it is important to consider the possible role of microorganisms, whose spectrum as a cause of balanoposthitis varies from aerobic and anaerobic, to viral and fungal microflora. Treatment approaches are determined by the etiological factors.</p></sec><sec><title>Conclusions</title><p>Conclusions. Balanoposthitis is a heterogeneous group of nosologies. The choice of treatment is based on the identified cause or empirically when possible. External therapy and hygiene constitute an essential part of treatment. When choosing drugs for topical glucocorticosteroids, preferenceshould be given to drugs with a high therapeutic index and low atrophogenic potential. Dysplastic processes of the penis are associated with human papillomavirus infection, the treatment of which can be both conservative and destructive.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>баланопостит</kwd><kwd>склероатрофических лихен</kwd><kwd>рубцовый фимоз</kwd><kwd>фимоз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>balanoposthitis</kwd><kwd>lichen sclerosus</kwd><kwd>cicatricial phimosis</kwd><kwd>phimosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Баланопостит. Методические рекомендации № 47 Департамента здравоохранения г. Москва, ГБУЗ «Московский научно-практический центр дерматовенерологии и косметологии» Н. Н. Потекаев, К. И. Забиров, В. И. Кисина и соавт., Москва, 2017. Balanoposthitis. Methodical recommendations No. 47 of the Department of Healthcare, Moscow, Moscow Scientific and Practical Center for Dermatovenereology and Cosmetology. N. N. Potekaev, K. I. Zabirov, V. I. Kisina et al., Moscow, 2017.</mixed-citation><mixed-citation xml:lang="en">Balanoposthitis. Methodical recommendations No. 47 of the Department of Healthcare, Moscow, Moscow Scientific and Practical Center for Dermatovenereology and Cosmetology. N. N. Potekaev, K. I. Zabirov, V. I. Kisina et al., Moscow, 2017.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Баланопостит. Руководство для врачей. Под редакцией К. И. Забирова. М. 2018. 200 с. Медицинское универсальное издательство Пульс. ISBN 978–5–99052–916–8. Balanoposthitis. A guide for doctors. Edited by K. I. Zabirov. M. 2018. 200 p. MedicalUniversal Publishing House Pulse. ISBN 978–5–99052–916–8.</mixed-citation><mixed-citation xml:lang="en">Balanoposthitis. A guide for doctors. Edited by K. I. Zabirov. M. 2018. 200 p. MedicalUniversal Publishing House Pulse. ISBN 978–5–99052–916–8.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Verma SB, Wollina U. Looking through the cracks of diabetic candidal balanoposthitis! Int J Gen Med. 2011; 4: 511–3.</mixed-citation><mixed-citation xml:lang="en">Verma SB, Wollina U. Looking through the cracks of diabetic candidal balanoposthitis! Int J Gen Med. 2011; 4: 511–3.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bromage SJ, Crump A, Pearce I. Phimosis as a presenting feature of diabetes. BJU Int. 2008 Feb; 101 (3): 338–40.</mixed-citation><mixed-citation xml:lang="en">Bromage SJ, Crump A, Pearce I. Phimosis as a presenting feature of diabetes. BJU Int. 2008 Feb; 101 (3): 338–40.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">А. А. Халдин, Д. В. Игнатьев, О. В. Чистик Баланит и баланопостит: современные подходы к рациональной наружной терапии. Современные проблемы дерматовенерологии, иммунологии и врачебной косметологии. № 1, Т. 1, с. 40–45. A. A. Khaldin, D. V. Ignatiev, O. V. Chistik Balanitis and balanoposthitis: modern approaches to rational external therapy. Modern problems of dermatovenerology, immunology and medical cosmetology. No. 1, V. 1, p. 40–45.</mixed-citation><mixed-citation xml:lang="en">А. A. Khaldin, D. V. Ignatiev, O. V. Chistik Balanitis and balanoposthitis: modern approaches to rational external therapy. Modern problems of dermatovenerology, immunology and medical cosmetology. No. 1, V. 1, p. 40–45.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Shim TN, Ali I, Muneer A, Bunker CB. Benign male genital dermatoses. BMJ. 2016 Aug 11; 354: i4337. DOI: 10.1136/bmj.i4337. PMID: 27514401.</mixed-citation><mixed-citation xml:lang="en">Shim TN, Ali I, Muneer A, Bunker CB. Benign male genital dermatoses. BMJ. 2016 Aug 11; 354: i4337. DOI: 10.1136/bmj.i4337. PMID: 27514401.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lebelo R. L., et al. Diversity of HPV types in cancerous and pre-cancerous penile lesions of South African men: implications for future HPV vaccination strategies. J Med Virol, 2014. 86: 257.</mixed-citation><mixed-citation xml:lang="en">Lebelo R. L., et al. Diversity of HPV types in cancerous and pre-cancerous penile lesions of South African men: implications for future HPV vaccination strategies. J Med Virol, 2014. 86: 257.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Parra-Sánchez M. Genital ulcers caused by herpes simplex virus. Enferm Infecc Microbiol Clin. 2019 Apr;37(4):260–264. English, Spanish. DOI: 10.1016/j.eimc.2018.10.020. Epub 2018 Dec 21. PMID: 30580877.</mixed-citation><mixed-citation xml:lang="en">Parra-Sánchez M. Genital ulcers caused by herpes simplex virus. Enferm Infecc Microbiol Clin. 2019 Apr;37(4):260–264. English, Spanish. DOI: 10.1016/j.eimc.2018.10.020. Epub 2018 Dec 21. PMID: 30580877.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lance B. Price, Cindy M. Liu., Kristine E. Johnson et al. The Effects of circumcision on the penis microbiome. PLoS ONE 5 (1): e8422. DOI: 10.1371/journal.pone.0008422. January 2010, Volume 5, Issue 1, e8422.</mixed-citation><mixed-citation xml:lang="en">Lance B. Price, Cindy M. Liu., Kristine E. Johnson et al. The Effects of circumcision on the penis microbiome. PLoS ONE 5 (1): e8422. DOI: 10.1371/journal.pone.0008422. January 2010, Volume 5, Issue 1, e8422.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Norimatsu Y, Ohno Y. Streptococcus pyogenes balanoposthitis. ID Cases. 2020 May 20; 21: e00832. DOI: 10.1016/j.idcr.2020. PMID: 32477873; PMCID: PMC 7248656.</mixed-citation><mixed-citation xml:lang="en">Norimatsu Y, Ohno Y. Streptococcus pyogenes balanoposthitis. ID Cases. 2020 May 20; 21: e00832. DOI: 10.1016/j.idcr.2020. PMID: 32477873; PMCID: PMC 7248656.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Parra-Sánchez M. Genital ulcers caused by herpes simplex virus. Enferm Infecc Microbiol Clin. 2019 Apr; 37 (4): 260–264. English, Spanish. DOI: 10.1016/j.eimc.2018.10.020. Epub 2018 Dec 21. PMID: 30580877.</mixed-citation><mixed-citation xml:lang="en">Parra-Sánchez M. Genital ulcers caused by herpes simplex virus. Enferm Infecc Microbiol Clin. 2019 Apr; 37 (4): 260–264. English, Spanish. DOI: 10.1016/j.eimc.2018.10.020. Epub 2018 Dec 21. PMID: 30580877.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bissessor L, Wilson J, McAuliffe G, Upton A. Audit of Trichomonas vaginalis test requesting by community referrers after a change from culture to molecular testing, including a cost analysis. N Z Med J. 2017 Jun 16; 130 (1457): 34–37. PMID: 28617786.</mixed-citation><mixed-citation xml:lang="en">Bissessor L, Wilson J, McAuliffe G, Upton A. Audit of Trichomonas vaginalis test requesting by community referrers after a change from culture to molecular testing, including a cost analysis. N Z Med J. 2017 Jun 16; 130 (1457): 34–37. PMID: 28617786.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dauendorffer JN, Amici JM, Renaud-Vilmer C, Cavelier-Balloy B. Comment réaliser une biopsie du pénis? [Surgical technique: punch biopsy for evaluation of penile dermatoses]. Ann Dermatol Venereol. 2014 Apr; 141 (4): 308–11. French. DOI: 10.1016/j.annder.2014.01.017. Epub 2014 Mar 21. PMID: 24703648.</mixed-citation><mixed-citation xml:lang="en">Dauendorffer JN, Amici JM, Renaud-Vilmer C, Cavelier-Balloy B. Comment réaliser une biopsie du pénis? [Surgical technique: punch biopsy for evaluation of penile dermatoses]. Ann Dermatol Venereol. 2014 Apr; 141 (4): 308–11. French. DOI: 10.1016/j.annder.2014.01.017. Epub 2014 Mar 21. PMID: 24703648.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Консенсус дерматологов стран СНГ по дерматитам и экземе. Consilium Medicum, Дерматология экстра-выпуск, 2014. Consensus of dermatologists of the CIS countries on dermatitis and eczema. Consilium Medicum, Dermatology Extra Issue, 2014.</mixed-citation><mixed-citation xml:lang="en">Consensus of dermatologists of the CIS countries on dermatitis and eczema. Consilium Medicum, Dermatology Extra Issue, 2014.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ebert AK, Rosch WH, Vogt T. Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. Eur Urol 2008; 54: 932–7.</mixed-citation><mixed-citation xml:lang="en">Ebert AK, Rosch WH, Vogt T. Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. Eur Urol 2008; 54: 932–7.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Luesley DM, Downey GP. Topical tacrolimus in the management of lichen sclerosus. BJOG 2006; 113:832–4.</mixed-citation><mixed-citation xml:lang="en">Luesley DM, Downey GP. Topical tacrolimus in the management of lichen sclerosus. BJOG 2006; 113:832–4.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Fischer G, Bradford J. Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma. J Reprod Med 2007; 52: 329–331.</mixed-citation><mixed-citation xml:lang="en">Fischer G, Bradford J. Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma. J Reprod Med 2007; 52: 329–331.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
